Skip to content
Home/Companies/Biotech/ADmit Therapeutics

ADmit Therapeutics

Biotech·Spain·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns ADmit Therapeutics?

ADmit Therapeutics is currently owned by Clave Mayor through Clave Innohealth FCR (2020 vintage), since 2023.

Hand-verified · updated 2026-08-09

Clave Mayor
Investor
Clave Mayor
Clave Innohealth FCR · 2020 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive

More from Clave Innohealth FCR

Other portfolio companies in the same fund.

Nanological
Nanological
Active
BiotechSpain· 2023
Corify Care
Active
MedTechSpain· 2021
Telum Therapeutics
Telum Therapeutics
Active
BiotechSpain· 2020

More Clave Mayor portfolio companies

From the same investor, across funds.

Agro Singularity
Active
AgTechSpain· 2021
Heura
Heura
Active
FoodTechSpain· 2021
Moa Foodtech
Active
FoodTechSpain· 2021
Predictheon
Active
MedTechSpain· 2021
Smileat
Active
FoodTechSpain· 2021
Polimerbio
Polimerbio
Active
MedTechSpain· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track ADmit Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on ADmit Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue